Skip to main content
. 2020 Oct;9(10):6479–6486. doi: 10.21037/tcr-20-2836

Table 2. Comparison of plasma retinoin-1 levels of colorectal cancer patients with different pathological parameters (x¯±s, ng/mL).

Pathological parameters Case Recurrence group (n=89) t/F P
Gender
   Male 182 70.32±20.47 0.962 0.337
   Female 137 67.99±22.61
Age (year)
   <60 171 68.19±24.35 0.967 0.334
   ≥60 148 70.63±20.08
Tumor site
   Colon 204 69.07±24.73 0.244 0.807
   Rectum 115 69.76±23.29
TNM staging
   I–II 135 65.92±25.43 2.370 0.018
   III–IV 184 71.81±18.96
Differentiated degree
   High and moderate differentiation 224 70.64±24.07 1.549 0.122
   Low differentiation 95 66.21±21.56
Pathological pattern
   Adenocarcinoma 229 70.02±21.80 0.938 0.349
   Others 90 67.54±22.35
Tumor types
   Infiltrating type 33 70.19±19.51 0.926 0.397
   Ulcerative type 164 70.78±21.74
   Protrude type 122 67.12±24.96
Lymphatic metastasis
   Yes 104 74.12±19.08 2.641 0.009
   No 215 66.86±24.16
Vessel carcinoma embolus
   Yes 76 74.19±18.62 1.700 0.090
   No 243 68.11±23.87